The Accelerated Access Review aims to set out new pathways for the development of medicines and medical technology, ultimately to give NHS patients quicker access. To add international insight, the Review asked RAND Europe to conduct a study. The aim was to identify and gain insight into international examples of best practice where the use of new drugs, devices and diagnostics were already being accelerated.
The study explored systems across the world through which drugs, devices and diagnostics pass rapidly, identifying what works both in theory and in practice.
The findings will feed into the wide ranging evidence base that the Accelerated Access Review team are collecting and analysing to support the review’s Chair, Sir Hugh Taylor, as he develops his thinking.